Scientific Advisory Board

EDI has gathered a world-class advisory board led by pharmaceutical industry veteran Dr David U'Prichard PhD. The SAB comprises of a panel of pharmaceutical industry experts with extensive experience in the drug discovery, small molecule, gene therapy and biologics, pre-clinical & clinical development, chemistry-manufacturing-controls (CMC), pharmaceutical sciences, pharmacology, drug safety, regulatory affairs, venture capital financing, business development, marketing and commercialization.  Board members also have extensive experience in the development of small molecule, biologics and oligonucleotide/gene-therapy based products.

Hugh Davis, PhD

Christine Debouck, PhD

David U’Prichard, PhD


Laurence Patterson, PhD

Patricia C Weber, PhD

Jenny Walsh, PhD

Lynne Georgopoulos, RN, MSHS, RAC

Steve Feldon, MD, MBA

Sarah E. Frew, PhD, MBA

Ron Newbold, PhD

Baiju Shah, JD

logo final_.png

Contact Us 

601 Elmwood Ave, Box EDI

Rochester, NY 14642

(585) 276-3150